Leading genetics experts call for more racial representation in their industry
As the Covid-19 pandemic has laid bare the racial inequalities in the United States’ healthcare…
Category: genetics
Early research from 23andMe strengthens link between blood types and Covid-19
A forthcoming study from genetic testing giant 23andMe shows that a person’s genetic code could…
Opinion: Real-time gene sequencing can help control — and may someday prevent — pandemics
As the novel coronavirus continues to infect people around the world, scientists have scrambled to…
23andMe’s next challenge: ensuring its customers can get drugs developed with their data
23andme has long been known as a consumer genetic testing unicorn. But CEO Anne Wojcicki…
The U.S. must do some heavy lifting to prepare for heritable genome editing
Countries contemplating giving the green light to heritable genome editing received specific guidance from an…
We’re not ready for more ‘CRISPR babies,’ expert panel warns, but it outlines steps before future attempts
Nearly two years after the birth of the first “CRISPR babies” stunned the world, an…
Opinion: Using telehealth to revolutionize the speed of making rare disease diagnoses
For a person living with a rare disease, it can take five years or longer…
Wary hemophilia patients say they’re willing to wait longer for a safe gene therapy
The Food and Drug Administration’s rejection of a gene therapy for hemophilia A on Wednesday…
Genomic sequencing to screen apparently healthy newborns raises more false alarms than routine blood tests, study finds
With advanced technology, clinicians can now sequence the genomes of newborn babies, seeking to turn…
Blackstone agrees to buy Ancestry in $4.7 billion deal
Investment firm Blackstone announced on Wednesday that it was scooping up direct-to-consumer genetics company Ancestry…
STAT Plus: Cancer drug is the first potential therapy to emerge from 23andMe and GlaxoSmithKline collaboration
The pharmaceutical giant GlaxoSmithKline is starting human trials of the first medicine, a cancer drug,…
Gene-editing discovery could point the way toward a ‘holy grail’: cures for mitochondrial diseases
Biologist David Liu was in the middle of his morning commute to the Broad Institute…
Two patients die in Audentes gene therapy study, heightening concerns over high-dose treatments
Two patients in a study of a high-dose gene therapy for a rare muscle disorder…
.jpg)
In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys
A form of CRISPR widely expected to be safer and possibly more effective that the…
He speaks at Black churches about genetics — and has some ideas about how to fix his field’s diversity problem
Over the past few weeks, 23andMe and other genetic testing companies have made headlines for…
Listen: The latest on treating Covid-19, vaccine politics, and diversifying genetics
Can a vaccine be an October surprise? Are journal publishers running a racket? And why…
23andMe says it’s ‘part of the problem’ on racial inequity. We asked geneticists what the company can do about it
At the consumer genetics giant 23andMe, CEO Anne Wojcicki last week issued a remarkable statement…
Opinion: The Bio Revolution is changing business and society
Imagine a world in which we can produce meat without animals, cure previously incurable diseases…
Hospital records hold valuable Covid-19 data. Making it usable is time-consuming work
As tens of thousands of people worldwide test positive for Covid-19 every day, researchers are…
23andMe study to recruit sickest Covid-19 patients in bid to unravel role of genetics in disease
As researchers probe DNA in search of clues about why some Covid-19 patients get so…
STAT Plus: Deluge of genome editing therapies end research drought for sickle cell disease
The newest publicly traded genome editing company, Beam Therapeutics, has gotten one of its experimental…
STAT Plus: Prominent Broad Institute scientist leaves to lead R&D at Genentech
A star scientist in the world of single-cell genomics and computational biology is leaving academia…
STAT Plus: ‘Science is very much a part of culture’: Siddhartha Mukherjee dives into the history of genetics in a new Ken Burns film
One of the world’s most well-known oncologists and one of the world’s most well-known documentary…
Listen: Pandemic exit strategies, how the outbreak affects patients, and Ken Burns takes on DNA
When will things go back to normal? What if a pandemic strikes when you’re already…
Genetic counselors push for permission to hold virtual visits with seniors covered by Medicare
Encouraged by new rules from the Trump administration, doctors and nurses across the country have…
STAT Plus: Gene and cell therapies continue growth in patients, financing, and costs
The number of people treated with approved gene therapies and gene-modified cell therapies like CAR-T…
In its first use inside the human body, CRISPR genome editing tested as blindness therapy
Scientists say they have used the gene editing tool CRISPR inside someone’s body for the…
Opinion: Human reproductive cloning: The curious incident of the dog in the night-time
Gregory: Is there any other point to which you would wish to draw my attention?Holmes:…
Opinion: Should ‘broken’ genes be fixed? My daughter changed the way I think about that question
I’m a doctor. I strive to fix things that are broken. Hearts, mostly. But my…
STAT Plus: Roche confirms departure of gene therapy pioneer Kathy High
Kathy High, a gene therapy pioneer who led the development of a treatment for a…
STAT Plus: FDA names genes that may interact with specific drugs, offering clarity to genetic testing industry
The burgeoning industry built around telling patients how their genes may interact with specific drugs…
Opinion: I was fortunate to get post-23andMe genetic counseling. Everyone should have that option
A year ago, I was shivering in the pre-op room at Cedars-Sinai Medical Center waiting…
A lottery like no other offers up a cutting-edge medicine — with lives on the line
The lottery that began this week was not about money, or about choosing a school,…
STAT Plus: Beam Therapeutics raises $180 million in IPO
Beam Therapeutics (BEAM), a Cambridge, Mass., genome-editing startup, raised $180 million in an initial public…
DNA sleuths read the coronavirus genome, tracing its origins and looking for dangerous mutations
As infectious disease specialists and epidemiologists race to contain the outbreak of the novel coronavirus…
23andMe laying off 14% of employees amid slump in DNA spit kit sales
In the latest sign of a slump in consumer genetic testing, 23andMe is laying off…
Previously unseen mutations in stem cells of young donors can be passed to recipients, study finds
Doctors use stem cell transplants to treat patients with certain cancers or blood disorders. And…
Watch: Consumer genetic testing: What do you get for your money?
There are about 6.4 billion individual letters in the human genome. More and more, advertisements…
Opinion: CRISPR babies scientist He Jiankui should not be villainized — or headed to prison
When I saw the news that He Jiankui and colleagues had been sentenced to three…
Opinion: He Jiankui is going to jail. Would the U.S. criminally prosecute a rogue gene-editing researcher?
On Monday, 13 months after He Jiankui announced that he had created the world’s first…
He Jiankui, who created world’s first CRISPR’d babies, sentenced to three years in prison
A Chinese court on Monday sentenced He Jiankui, the scientist who made the world’s first…
Scientists aren’t sure why identical twins differ. Armadillo quads offer an answer
One of the armadillo quadruplets runs away when she hears Amanda Withnell approaching; her three…
STAT Plus: Creating Pig3.0, the world’s most CRISPR’d animal, raises hopes of transplantable organs
A biotechnology company that is trying to create CRISPR-edited pigs so their organs could be…
STAT Plus: As families in Europe clamor for its pricey gene therapy, Novartis creates a lottery
Seeking to provide its pricey gene therapy to patients in countries where the drug is…
Waning treatment for immune deficiency is a warning for all ‘one-and-done’ therapies
As a new mother, she didn’t know to look for blue-tinged lips. She could just…
Opinion: Manufacturing: the next breakthrough in gene therapy
I never thought I’d see the day when words like “process,” “scale,” and “automation” would…
.jpg)
The FTC moves to block DNA sequencer Illumina’s acquisition of PacBio, calling company a ‘monopolist’
The Federal Trade Commission is challenging DNA sequencing giant Illumina’s proposed $1.2 billion purchase of…
FDA changes course on Sarepta’s once-rejected muscular dystrophy drug
The Food and Drug Administration reversed its decision on a treatment for Duchenne muscular dystrophy…
STAT Plus: Watch: Dr. James Wilson, a scientific pioneer, on the future of gene therapy
Dr. James Wilson is a pioneer in gene therapy. That does not mean he is…
STAT Plus: Veritas, genetics company founded by George Church, suspends U.S. operations
Veritas Genetics, the Boston-based personal genome testing company co-founded by noted Harvard Medical School professor…